logo
Directory Last Updated: 20 November 2024
Return to Directory Key Opinion Leaders in Clinical Trials Areas - word selected:- LAM
Names, CVs (as available), locations and contact details of Investigators are available to Subscribers.
To subscribe, please contact Emma Taylor at emma@specialistinfo.com or 01423 727 724 for details on subscription costs.
Page No 1
PhraseConsultantTownSpecial Interests
Lymphangioleiomyomatosis - LAM
*Consultant(s)*
*Towns*Lymphangioleiomyomatosis - LAM, rare lung diseases, interstitial lung disease
Lymphangioleiomyomatosis - LAM
*Consultant(s)*
*Towns*Idiopathic pulmonary fibrosis - IPF, sarcoidosis, connective tissue disease associated lung disease, hypersensitivity pneumonitis, Langerhan's cell histiocytosis, Lymphangioleiomyomatosis - LAM, rare lung disease, interstitial lung disease
Page No 1
Spacer

Third Party Advertisement

Adverts by Google